[{"id":"6874df97-e833-4a9e-bd15-5cc442d40050","acronym":"","url":"https://clinicaltrials.gov/study/NCT05377827","created_at":"2022-05-17T11:53:47.550Z","updated_at":"2024-07-02T16:35:33.726Z","phase":"Phase 1","brief_title":"Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies","source_id_and_acronym":"NCT05377827","lead_sponsor":"Washington University School of Medicine","biomarkers":" CD7","pipe":" | ","alterations":" CD7 expression","tags":["CD7"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD7 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e soficabtagene geleucel (WU CART 007)"],"overall_status":"Recruiting","enrollment":" Enrollment 54","initiation":"Initiation: 10/10/2023","start_date":" 10/10/2023","primary_txt":" Primary completion: 04/30/2026","primary_completion_date":" 04/30/2026","study_txt":" Completion: 04/30/2026","study_completion_date":" 04/30/2026","last_update_posted":"2023-10-12"}]